DNA RNA and Cells

19 Sep 2017 Incysus Submits Investigational New Drug (IND) Application for Allogeneic Gamma-Delta T Cell Immunotherapy for Leukemia and Lymphoma
19 Sep 2017 Formula Pharmaceuticals Announces Initiation of the First Clinical Trial for Allogeneic CIK-CAR Cancer Immunotherapy
19 Sep 2017 Autolus commences clinical trial programmes
14 Sep 2017 Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates
14 Sep 2017 Moderna Announces Pipeline and Corporate Update
14 Sep 2017 Mustang Bio Announces Expansion of CAR T Pipeline into CD20-Directed Immunotherapies
14 Sep 2017 Oncolytics Biotech® Announces First Patient Treated in MUK eleven Study
13 Sep 2017 Iovance Biotherapeutics Announces Approval of First Clinical Trial Application by Competent Authority in Netherlands for a Phase 2 Trial of LN-145 for the Treatment of Patients with Cervical Cancer
12 Sep 2017 miRagen Therapeutics Presents New MRG-201 Preclinical Data for Inhaled MicroRNA-29 Mimic Targeting Pulmonary Fibrosis
11 Sep 2017 New Data Presented at European Society for Medical Oncology Meeting Demonstrate Antitumor Activity with IONIS-STAT3-2.5 Rx in Combination with Imfinzi
11 Sep 2017 Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer (NSCLC)
11 Sep 2017 Oncolytics Biotech® Announces the Presentation of REOLYSIN® Clinical Data at ESMO 2017 Congress
08 Sep 2017 Idera Pharmaceuticals Presents Pre-Clinical Data from IMO-2125 Treatment in Combination with Ipilimumab that Demonstrates Induction of Durable Anti-tumor Responses Associated with Tumor-Specific Memory
07 Sep 2017 Sanofi Alliance Partner Alnylam Provides Update on Fitusiran Development Program
07 Sep 2017 GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO
06 Sep 2017 Longeveron Initiates Phase 2b Stem Cell Therapy Trial to Treat Aging Frailty
06 Sep 2017 Sarepta Therapeutics Announces Positive Results in Its Study Evaluating Gene Expression, Dystrophin Production, and Dystrophin Localization in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53 Treated with Golodirsen (SRP-4053)
06 Sep 2017 Poseida Therapeutics Presents Novel BCMA-Specific CAR-T Therapy at CAR-TCR Summit
06 Sep 2017 Endocyte Presents Data at the 2017 CAR-TCR Summit Further Demonstrating the Ability to Manage Cytokine Release Syndrome Related to CAR T-Cell Therapy
06 Sep 2017 Agilis Biotherapeutics Updates Progress of its CNS Gene Therapy for AADC Deficiency
06 Sep 2017 ORYX to present positive clinical data with oncolytic virus ParvOryx in combination with immune activators at the Third CRI-CIMT-EATI-AACR Conference
05 Sep 2017 Cellectis Reports Clinical Hold of UCART123 Studies
31 Aug 2017 Dimension Therapeutics Commences Patient Dosing in Global, Multi-Center Phase 1/2 Clinical Trial of DTX301 in Ornithine Transcarbamylase (OTC) Deficiency
31 Aug 2017 Akcea and Ionis Announce Submission of New Drug Application for Volanesorsen to the U.S. FDA
30 Aug 2017 Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing